FE

Fermi Inc.

FRMI | US

Overview

Corporate Details

ISIN(s):
US3149111086
LEI:
529900TSHBYBCFMYZ228
Country:
United States of America
Address:
N/A
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 13:10
Environmental & Social Information
Fermi and MVM EGI Announce Hybrid Cooling MOU
English 13.9 KB
2025-11-25 08:20
Capital/Financing Update
Response to Speculation
English 10.1 KB
2025-11-13 08:25
Report Publication Announcement
Publication of Fermi Inc. Interim Financial Report
English 10.3 KB
2025-11-11 08:25
Report Publication Announcement
Fermi Posts Third Quarter 2025 Shareholder Letter
English 13.6 KB
2025-11-06 08:25
Regulatory Filings
Advance in Aid of Construction Agreement
English 10.3 KB
2025-11-05 08:25
Report Publication Announcement
Notice of Inaugural Earnings Call
English 13.9 KB
2025-11-04 08:30
Environmental & Social Information
State of Texas Preliminary Approval for First 6GW
English 19.6 KB
2025-10-30 08:00
Regulatory Filings
Partnerships Announcement
English 14.9 KB

Automate Your Workflow. Get a real-time feed of all Fermi Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fermi Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fermi Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden
RESP
REVELATION BIOSCIENCES, INC. Logo
Develops therapies that reprogram the innate immune system to reduce inflammation-related damage.
United States of America
REVB
REVIVA PHARMACEUTICALS HOLDINGS, INC. Logo
Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.
United States of America
RVPH
Revolution Medicines, Inc. Logo
A clinical-stage oncology company developing targeted therapies for RAS-addicted cancers.
United States of America
RVMD
ROKIT HEALTHCARE Inc. Logo
Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.
South Korea
376900
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom
ROQ
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland
RVU
Salarius Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.
United States of America
SLRX
SaltX Technology Holding B Logo
Develops electric calcination tech to decarbonize heavy industries like cement and capture CO2.
Sweden
SALT

Talk to a Data Expert

Have a question? We'll get back to you promptly.